Analysis of T-cell and NK-cell immunity in chronic myelogenous leukemia
Latest Information Update: 23 Jul 2020
At a glance
- Drugs Dasatinib (Primary) ; Imatinib (Primary) ; Nilotinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 23 Jul 2020 New trial record
- 21 Jun 2020 Results of subgroup analysis evaluating the association between TFR and HLA and KIR polymorphisms in patients that discontinued TKIs, and to compare the results with those obtained after genotyping of KIRs and HLAs, presented at the 25th Congress of the European Haematology Association.